| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 8 | -210,453 | 100% | $185.47 | -$39,033,086 |
| Net | -8 | -210,453 | -100% | -$39,033,086 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| STEPHEN H. RUSCKOWSKI | Director | $47,867,056 | 06 Mar 2023 | ||
| J. E. Davis | CEO and President, Director | $26,940,369 | -$17,191,834 | -39% | 18 Feb 2026 |
| Catherine T. Doherty | EVP, Regional Businesses | $14,861,622 | -$6,890,510 | -32% | 18 Feb 2026 |
| Mark Guinan | Executive Vice President & CFO | $13,108,142 | 07 Mar 2022 | ||
| MICHAEL E. PREVOZNIK | SVP & General Counsel | $8,943,726 | -$6,580,830 | -42% | 18 Feb 2026 |
| TIMOTHY M. RING | Director | $7,948,934 | 01 Oct 2025 | ||
| MANNER CARRIE EGLINTON | SVP, Advanced Diagnostics | $7,592,213 | 07 Mar 2022 | ||
| MICHAEL J. DEPPE | SVP, Corp. Controller & CAO | $7,437,535 | 18 Feb 2026 | ||
| SAM SAMAD | Executive Vice President & CFO | $6,629,497 | 18 Feb 2026 | ||
| GARY M. PFEIFFER | Director | $5,368,214 | -$270,317 | -4.8% | 22 Oct 2025 |
| TIMOTHY L. MAIN | Director | $4,646,153 | 15 May 2025 | ||
| GAIL R. WILENSKY | Director | $4,162,722 | 17 May 2023 | ||
| Patrick Plewman | SVP for Diagnostic Services | $3,244,097 | -$3,870,131 | -54% | 18 Feb 2026 |
| Vicky B. Gregg | Director | $3,138,806 | -$239,700 | -7.1% | 28 Jan 2026 |
| MARK E. DELANEY | SVP & Chief Commercial Officer | $2,668,483 | -$1,795,483 | -40% | 18 Feb 2026 |
| KARTHIK KUPPUSAMY | SVP, Clinical Solutions | $2,227,444 | -$2,194,281 | -50% | 18 Feb 2026 |
| DENISE M. MORRISON | Director | $1,897,896 | 15 May 2025 | ||
| Wright Lassiter III | Director | $1,722,051 | 28 Jan 2026 | ||
| MARK A. GARDNER | SVP of Molecular Gen & Oncol | $1,539,829 | 24 Sep 2024 | ||
| Tracey Doi | Director | $1,146,653 | 15 May 2025 | ||
| Helen Torley | Director | $769,122 | 25 May 2021 | ||
| Luis Diaz | Director | $716,260 | 15 May 2025 | ||
| ROBERT B. CARTER | Director | $496,211 | 28 Jan 2026 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|